Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:54 PM
Ignite Modification Date:
2025-12-24 @ 2:54 PM
NCT ID:
NCT01778959
Eligibility Criteria:
Inclusion Criteria:
* Age-related cataract
* Age 21 and older
* written informed consent prior to surgery
* Small pupil group: Patients with a pupil size below 4.0 mm after pharmacological dilation with tropicamide 1% and phenylephrine 2.5% gtt as used routinely for pupil dilation,
* IFIS group: Patients, who currently are or have been treated with Alpha-adrenergic receptor antagonists (Tamsulosin- i.e. Alna ret.®)
Exclusion Criteria:
* Pregnancy (pregnancy test will be taken pre-operatively in women of reproductive age)
* Traumatic cataract
* History of uveitis
* Any ophthalmic pathology that could compromise the measurements
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
21 Years
Study:
NCT01778959
Study Brief:
Protocol Section:
NCT01778959